Evofem Biosciences Announces Financial Results for the First Quarter of 2024

SAN DIEGO, May 15, 2024 /PRNewswire/ — The company behind the hormone-free contraceptive Phexxi® (lactic acid, citric acid and potassium bitartrate), Evofem Biosciences, Inc. (“Evofem” or “the Company”) (OTCQB: EVFM) today announced financial results for the first quarter of 2024….

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks